USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in Science, ...

These cells present antigens – fragments of pathogens – to the T cells and activate them through various signals. The activation process lasts about 24 hours. During this time, T cells remain in ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...